Cargando…
Costs of Drug Therapy in Patients with Ankylosing Spondylitis in Brazil
INTRODUCTION: The Brazilian Public Health System offers free-of-charge drug treatment for ankylosing spondylitis (AS) to all Brazilian citizens. We report here the first population-based cohort study on patients with AS in Brazil. The aim of this study was to evaluate the costs of the tumour necrosi...
Autores principales: | Machado, Marina Amaral de Ávila, Ferre, Felipe, Moura, Cristiano Soares de, Almeida, Alessandra Maciel, Andrade, Eli Iola Gurgel, Cherchiglia, Mariângela Leal, Acurcio, Francisco de Assis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127960/ https://www.ncbi.nlm.nih.gov/pubmed/27747578 http://dx.doi.org/10.1007/s40744-016-0036-0 |
Ejemplares similares
-
Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis
por: Machado, Marina Amaral de Ávila, et al.
Publicado: (2016) -
Legal and health variations in drug litigation injunctions granted in Minas Gerais
por: Coelho, Tiago Lopes, et al.
Publicado: (2014) -
Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil
por: Guerra, Augusto Afonso, et al.
Publicado: (2015) -
Health self-assessment by hemodialysis patients in the Brazilian Unified Health System
por: Moreira, Tiago Ricardo, et al.
Publicado: (2016) -
Patient survival and risk of death after prostate cancer treatment in the Brazilian Unified Health System
por: Braga, Sonia Faria Mendes, et al.
Publicado: (2017)